Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.
2.

Pathophysiology of insulin secretion in non-insulin-dependent diabetes mellitus.

Ward WK, Beard JC, Halter JB, Pfeifer MA, Porte D Jr.

Diabetes Care. 1984 Sep-Oct;7(5):491-502.

PMID:
6094129
3.

Insulin secretion in diabetes mellitus.

Pfeifer MA, Halter JB, Porte D Jr.

Am J Med. 1981 Mar;70(3):579-88.

PMID:
7011013
4.

Insulin secretion in obese and non-obese NIDDM.

Cerasi E, Nesher R, Gadot M, Gross D, Kaiser N.

Diabetes Res Clin Pract. 1995 Aug;28 Suppl:S27-37. Review.

PMID:
8529516
5.

The third phase of in vitro insulin secretion. Evidence for glucose insensitivity.

Bolaffi JL, Heldt A, Lewis LD, Grodsky GM.

Diabetes. 1986 Mar;35(3):370-3.

PMID:
3512347
6.

Cellular and molecular biology of the beta cell.

Steiner DF, James DE.

Diabetologia. 1992 Dec;35 Suppl 2:S41-8. Review.

PMID:
1478377
7.

Alteration of beta-cell constitutive NO synthase activity is involved in the abnormal insulin response to arginine in a new rat model of type 2 diabetes.

Novelli M, Pocai A, Lajoix AD, Beffy P, Bezzi D, Marchetti P, Gross R, Masiello P.

Mol Cell Endocrinol. 2004 Apr 30;219(1-2):77-82.

PMID:
15149729
8.

Inhibition of glucose-stimulated insulin release from beta TC3 cells and rodent islets by an analog of FK506.

Herold KC, Nagamatsu S, Buse JB, Kulsakdinun P, Steiner DF.

Transplantation. 1993 Jan;55(1):186-92.

PMID:
7678356
9.
10.

Evolution of beta-cell dysfunction in the male Zucker diabetic fatty rat.

Tokuyama Y, Sturis J, DePaoli AM, Takeda J, Stoffel M, Tang J, Sun X, Polonsky KS, Bell GI.

Diabetes. 1995 Dec;44(12):1447-57.

PMID:
7589853
11.

The constitutive secretory pathway is a major route for islet amyloid polypeptide secretion in neonatal but not adult rat islet cells.

Verchere CB, D'Alessio DA, Prigeon RL, Hull RL, Kahn SE.

Diabetes. 2000 Sep;49(9):1477-84.

PMID:
10969831
12.

Leptin regulation of islet amyloid polypeptide secretion from mouse pancreatic islets.

Karlsson E, Stridsberg M, Sandler S.

Biochem Pharmacol. 1998 Nov 15;56(10):1339-46.

PMID:
9825733
13.

Desensitization of the insulin-secreting beta cell.

Grodsky GM, Bolaffi JL.

J Cell Biochem. 1992 Jan;48(1):3-11. Review.

PMID:
1316359
14.

Basal insulin hypersecretion in insulin-resistant Zucker diabetic and Zucker fatty rats: role of enhanced fuel metabolism.

Zhou YP, Cockburn BN, Pugh W, Polonsky KS.

Metabolism. 1999 Jul;48(7):857-64.

PMID:
10421226
15.

[And what about diabetes?].

Cerasi E.

Bull Acad Natl Med. 2007 Apr-May;191(4-5):941-3; discussion 943. French.

PMID:
18225448
17.

Inhibition of insulin secretion as a new drug target in the treatment of metabolic disorders.

Hansen JB, Arkhammar PO, Bodvarsdottir TB, Wahl P.

Curr Med Chem. 2004 Jun;11(12):1595-615. Review.

PMID:
15180566
18.

Islet dysfunction in non-insulin-dependent diabetes mellitus.

Kahn SE, Porte D Jr.

Am J Med. 1988 Nov 28;85(5A):4-8. Review.

PMID:
3057894
19.

Experimental benefit of moxonidine on glucose metabolism and insulin secretion in the fructose-fed rat.

Rösen P, Ohly P, Gleichmann H.

J Hypertens Suppl. 1997 Jan;15(1):S31-8.

PMID:
9050983
20.

Islet amyloid polypeptide (IAPP) secretion from pancreatic islets isolated from non-obese diabetic (NOD) mice.

Karlsson E, Stridsberg M, Sandler S.

Regul Pept. 1996 May 7;63(1):39-45.

PMID:
8795087

Supplemental Content

Support Center